acetylglucosamine has been researched along with Mastocytosis, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agopian, J; Asara, JM; Brenet, F; Castellano, R; Chelbi, R; Da Costa, Q; De Sepulveda, P; Dubreuil, P; Goubard, A; Hermine, O; Kousteridou, P; Maurizio, J; Nguyen, QV; Orfao, A; Scorrano, G; Teodosio, C; Yuan, M | 1 |
1 other study(ies) available for acetylglucosamine and Mastocytosis, Systemic
| Article | Year |
|---|---|
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness.
Topics: Acetylglucosamine; Adult; Animals; Chromatin Assembly and Disassembly; Disease Progression; Humans; Mast Cells; Mastocytosis, Systemic; Metabolome; Mice, SCID; Prospective Studies | 2021 |